New eye drop trial offers hope for cornea damage patients
NCT ID NCT07422389
Summary
This trial provides access to experimental BRM421 eye drops for adults with mild to moderate limbal stem cell deficiency, a condition that can damage the cornea and affect vision. Participants will use the drops twice daily for at least 12 weeks and visit the clinic monthly for checkups. The goal is to see if BRM421 can help control the disease in patients who are not satisfied with current standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMBAL STEM CELL DEFICIENCY (LSCD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Scheie Eye Institute
AVAILABLEPhiladelphia, Pennsylvania, 19104, United States
Contact
Conditions
Explore the condition pages connected to this study.